Immunovant, Inc. (IMVT) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Roivant Sciences Ltd. mit 113,317,007 Aktien. Weitere bedeutende Anteilseigner sind Health Sciences Holdings, LLC und Salzmann Peter.
In den letzten 12 Monaten haben Insider 30 Transaktionen in IMVT Aktien getätigt — 5 Käufe (im Wert von $353.18M) und 21 Verkäufe (im Wert von $937.25K). Insider-Verkäufe haben die Käufe in diesem Zeitraum übertroffen.
IMVT Insider-Beteiligungen
Größter Aktionär
Roivant Sciences Ltd.
113,317,007 Aktien
Käufe (12 Monate)
5
$353.18M Wert
Verkäufe (12 Monate)
21
$937.25K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Roivant Sciences Ltd. |
10 Percent Owner |
113,317,007 |
2025-12-12 |
|
| 2 |
Health Sciences Holdings, Llc |
10 Percent Owner |
10,000,000 |
2019-05-15 |
|
| 3 |
Salzmann Peter |
Chief Executive Officer |
1,178,191 |
2025-04-17 |
|
| 4 |
Wong Roderick |
Chief Executive Officer |
902,498 |
2019-12-13 |
|
| 5 |
Butchko Julia G. |
Chief Development Officer |
440,959 |
2024-08-23 |
|
| 6 |
Barnett Eva Renee |
Chief Financial Officer |
396,774 |
2025-04-17 |
|
| 7 |
Zeldin Robert K |
Chief Medical Officer |
380,325 |
2019-12-20 |
|
| 8 |
Macias William L. |
Chief Medical Officer |
357,353 |
2025-02-21 |
|
| 9 |
Levine Mark S. |
Chief Legal Officer |
319,228 |
2024-11-22 |
|
| 10 |
Geffner Michael |
Chief Medical Officer |
217,958 |
2025-10-24 |
|
| 11 |
Girao Tiago |
Chief Financial Officer |
208,388 |
2025-05-05 |
|
| 12 |
Stout Jay S |
Chief Technology Officer |
197,634 |
2026-01-23 |
|
| 13 |
Gloria Melanie |
Chief Operating Officer |
170,273 |
2026-02-27 |
|
| 14 |
Van Tuyl Christopher |
Chief Legal Officer |
147,053 |
2026-03-20 |
|
| 15 |
Middlekauff W Bradford |
General Counsel |
142,600 |
2020-05-18 |
|
| 16 |
Hughes Douglas J. |
Director |
120,773 |
2025-12-03 |
|
| 17 |
Jain Rita |
Chief Medical Officer |
117,600 |
2021-03-31 |
|
| 18 |
Elliott Michael James |
Chief Scientific Officer |
97,600 |
2021-03-23 |
|
| 19 |
Torti Frank |
Director |
93,599 |
2025-04-03 |
|
| 20 |
Fromkin Andrew J. |
Director |
85,852 |
2025-12-03 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-02 |
Venker Eric |
Chief Executive Officer |
Informierter Verkauf |
1,409 |
$24.60 |
$34.66K |
| 2026-04-01 |
Venker Eric |
Chief Executive Officer |
Aktienrückgabe |
334,960 |
$25.10 |
$8.41M |
| 2026-03-18 |
Van Tuyl Christopher |
Chief Legal Officer |
Informierter Verkauf |
2,877 |
$24.97 |
$71.84K |
| 2026-02-25 |
Gloria Melanie |
Chief Operating Officer |
Informierter Verkauf |
942 |
$28.90 |
$27.22K |
| 2026-01-21 |
Stout Jay S |
Chief Technology Officer |
Informierter Verkauf |
1,977 |
$26.03 |
$51.46K |
| 2026-01-07 |
Stout Jay S |
Chief Technology Officer |
Informierter Verkauf |
55 |
$26.92 |
$1.48K |
| 2025-12-18 |
Van Tuyl Christopher |
Chief Legal Officer |
Informierter Verkauf |
2,284 |
$27.38 |
$62.54K |
| 2025-12-12 |
Roivant Sciences Ltd. |
10 Percent Owner |
Informierter Kauf |
16,666,666 |
$21.00 |
$350M |
| 2025-12-01 |
Hughes Douglas J. |
Director |
Informierter Verkauf |
1,909 |
$23.96 |
$45.74K |
| 2025-12-01 |
Fromkin Andrew J. |
Director |
Informierter Verkauf |
2,898 |
$23.95 |
$69.41K |
| 2025-11-20 |
Gloria Melanie |
Chief Operating Officer |
Informierter Verkauf |
2,375 |
$23.97 |
$56.93K |
| 2025-10-22 |
Geffner Michael |
Chief Medical Officer |
Informierter Verkauf |
2,595 |
$19.03 |
$49.38K |
| 2025-10-22 |
Stout Jay S |
Chief Technology Officer |
Informierter Verkauf |
2,520 |
$19.03 |
$47.96K |
| 2025-10-08 |
Geffner Michael |
Chief Medical Officer |
Informierter Verkauf |
1,272 |
$16.30 |
$20.73K |
| 2025-10-08 |
Stout Jay S |
Chief Technology Officer |
Informierter Verkauf |
1,585 |
$16.30 |
$25.84K |
| 2025-07-28 |
Venker Eric |
Chief Executive Officer |
RSU-Zuteilung |
189,900 |
$16.76 |
$3.18M |
| 2025-07-23 |
Geffner Michael |
Chief Medical Officer |
Informierter Verkauf |
2,385 |
$18.15 |
$43.29K |
| 2025-07-23 |
Stout Jay S |
Chief Technology Officer |
Informierter Verkauf |
2,805 |
$18.15 |
$50.91K |
| 2025-07-09 |
Geffner Michael |
Chief Medical Officer |
Informierter Verkauf |
1,160 |
$17.24 |
$20K |
| 2025-07-09 |
Stout Jay S |
Chief Technology Officer |
Informierter Verkauf |
1,519 |
$17.24 |
$26.19K |
| 2025-05-01 |
Susman Robert Graham |
Director |
RSU-Zuteilung |
25,016 |
- |
- |
| 2025-05-01 |
Bauer Jake |
Director |
RSU-Zuteilung |
25,016 |
- |
- |
| 2025-05-01 |
Girao Tiago |
Chief Financial Officer |
RSU-Zuteilung |
208,388 |
- |
- |
| 2025-04-18 |
Susman Robert Graham |
Officer |
Unbekannt |
- |
- |
- |
| 2025-04-18 |
Bauer Jake |
Officer |
Unbekannt |
- |
- |
- |
